MET Gene Status in Malignant Mesothelioma Using Fluorescent In Situ Hybridization
J Thorac Oncol
.
2016 Feb;11(2):e28-30.
doi: 10.1016/j.jtho.2015.10.019.
Authors
Serena Varesano
1
,
Sandra Salvi
1
,
Simona Boccardo
1
,
Jean Louis Ravetti
1
,
Maria Pia Pistillo
2
,
Pier Aldo Canessa
3
,
Paola Ferro
4
,
Franco Fedeli
4
,
Silvio Roncella
5
Affiliations
1
Division of Histopathology and Cytopathology, IRCCS A.O.U. San Martino-IST, Genova, Italy.
2
Unit of Tumor Epigenetics, IRCCS A.O.U. San Martino-IST, Genova, Italy.
3
Division of Pneumology, ASL5, La Spezia, Italy.
4
Division of Histopathology and Cytopathology, ASL5, La Spezia, Italy.
5
Division of Histopathology and Cytopathology, ASL5, La Spezia, Italy. Electronic address:
[email protected]
.
PMID:
26811229
DOI:
10.1016/j.jtho.2015.10.019
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
In Situ Hybridization
In Situ Hybridization, Fluorescence*
Lung Neoplasms / genetics*
Mesothelioma
Pleural Neoplasms